IBS and IBD Quiz PDF

1. What is a hallmark feature of irritable bowel syndrome (IBS)? a) Chronic abdominal pain with altered bowel habits b) Bloody diarrhea c) Fistula formation d) Weight loss Answer: a) Chronic abdominal pain with altered bowel habits 2. Which IBS subtype is characterized by constipation-predominance?...

1. What is a hallmark feature of irritable bowel syndrome (IBS)? a) Chronic abdominal pain with altered bowel habits b) Bloody diarrhea c) Fistula formation d) Weight loss Answer: a) Chronic abdominal pain with altered bowel habits 2. Which IBS subtype is characterized by constipation-predominance? a) IBS-D b) IBS-C c) IBS-M d) IBS-P Answer: b) IBS-C 3. Which of the following is a risk factor for developing IBS? a) Older age (>65 years) b) History of anxiety or depression c) Male sex d) History of gastric ulcers Answer: b) History of anxiety or depression 4. What dietary intervention is recommended for IBS management? a) High-fat diet b) Low FODMAP diet c) Gluten-free diet d) Ketogenic diet Answer: b) Low FODMAP diet 5. Which pharmacologic agent is indicated for IBS-C? a) Loperamide b) Lubiprostone c) Rifaximin d) Dicyclomine Answer: b) Lubiprostone 6. What is a common nonpharmacologic therapy for IBS? a) Cognitive behavioral therapy b) Endoscopy c) Surgery d) Chemotherapy Answer: a) Cognitive behavioral therapy 7. Which symptom is more common in ulcerative colitis compared to Crohn’s disease? a) Blood in stool b) Perianal fistulas c) Skip lesions d) Malabsorption Answer: a) Blood in stool 8. What is the primary location of Crohn’s disease inflammation? a) Rectum only b) Entire GI tract c) Sigmoid colon only d) Jejunum only Answer: b) Entire GI tract 9. What is a common complication of ulcerative colitis? a) Toxic megacolon b) Fistula formation c) Small bowel cancer d) B12 deficiency Answer: a) Toxic megacolon 10. Which therapy is first-line for mild-moderate ulcerative colitis? a) Methotrexate b) Mesalamine c) Infliximab d) Prednisone Answer: b) Mesalamine 11. What is the goal of therapy for inflammatory bowel disease (IBD)? a) Induce and maintain remission b) Promote weight loss c) Prevent gallstones d) Increase bowel frequency Answer: a) Induce and maintain remission 12. Which biologic agent targets tumor necrosis factor (TNF) in IBD? a) Vedolizumab b) Infliximab c) Ustekinumab d) Methotrexate Answer: b) Infliximab 13. Which medication is primarily used for fistulas in Crohn’s disease? a) Azathioprine b) Infliximab c) Mesalamine d) Ciprofloxacin Answer: b) Infliximab 14. What nonpharmacologic measure is beneficial in IBS management? a) Regular physical activity b) Total bowel rest c) Gluten-free diet for all d) High-fat diet Answer: a) Regular physical activity 15. Which pharmacologic therapy is indicated for refractory IBS-D? a) Rifaximin b) Polyethylene glycol c) Linaclotide d) Psyllium Answer: a) Rifaximin 16. What is the mechanism of action of mesalamine in IBD? a) Blocks TNF-alpha b) Reduces inflammation in the GI tract c) Prevents B-cell activation d) Stimulates intestinal motility Answer: b) Reduces inflammation in the GI tract 17. What is a black-box warning for methotrexate use in IBD? a) Tendon rupture b) Hepatotoxicity c) QT prolongation d) Renal failure Answer: b) Hepatotoxicity 18. Which biologic agent prevents immune cell migration to the gut? a) Vedolizumab b) Adalimumab c) Azathioprine d) Sulfasalazine Answer: a) Vedolizumab 19. Which IBD subtype is associated with skip lesions? a) Ulcerative colitis b) Crohn’s disease c) Irritable bowel syndrome d) Microscopic colitis Answer: b) Crohn’s disease 20. What dietary modification is commonly used for mild IBS symptoms? a) Increased insoluble fiber b) Low FODMAP diet c) High-protein diet d) Total parenteral nutrition Answer: b) Low FODMAP diet